|
Volumn 234, Issue , 1998, Pages 83-96
|
Clinical trials with Pseudomonas exotoxin immunotoxins
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY CONJUGATE;
IMMUNOGLOBULIN G1;
IMMUNOGLOBULIN G2B;
IMMUNOTOXIN;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LMB 1 IMMUNOTOXIN;
LMB 7 IMMUNOTOXIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY B 3 LYS PSEUDOMONAS EXOTOXIN 38;
MONOCLONAL ANTIBODY E 23(FV) PSEUDOMONAS EXOTOXIN 38;
MONOCLONAL ANTIBODY OVB 3 PSEUDOMONAS EXOTOXIN;
MUTANT PROTEIN;
PROTEIN P53;
PSEUDOMONAS EXOTOXIN;
RECOMBINANT PROTEIN;
TRANSFORMING GROWTH FACTOR ALPHA PSEUDOMONAS EXOTOXIN 40;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTIBODY SPECIFICITY;
BREAST CARCINOMA;
CAPILLARY LEAK SYNDROME;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON CARCINOMA;
DOSE RESPONSE;
DRUG CONJUGATION;
DRUG MECHANISM;
EDEMA;
FEMALE;
FEVER;
HEADACHE;
HUMAN;
HYPOALBUMINEMIA;
HYPOTENSION;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRATUMORAL DRUG ADMINISTRATION;
KIDNEY CARCINOMA;
MALE;
NEUROTOXICITY;
OLIGURIA;
OVARY CARCINOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
RASH;
REVIEW;
TRANSITIONAL CELL CARCINOMA;
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS EXOTOXIN;
|
EID: 0031838498
PISSN: 0070217X
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-3-642-72153-3_6 Document Type: Review |
Times cited : (19)
|
References (10)
|